Research Progress on Icariin Promoting Bone Injury Repair and Regeneration
View abstract on PubMed
Summary
This summary is machine-generated.Icariin (ICA) shows promise for bone repair by promoting bone formation and reducing resorption. However, poor bioavailability necessitates advanced delivery systems for effective therapeutic use in orthopedic applications.
Area Of Science
- Biomaterials Science
- Regenerative Medicine
- Pharmacology
Background
- Icariin (ICA), a flavonoid from Epimedium plants, is investigated for bone tissue repair.
- ICA influences osteogenic differentiation of mesenchymal stem cells (MSCs) and bone remodeling.
- ICA also offers anti-inflammatory, antioxidant, and pro-angiogenic effects, improving the local microenvironment.
Purpose Of The Study
- To review the multi-modal actions of Icariin (ICA) in bone regeneration.
- To highlight ICA's potential in promoting bone and cartilage tissue repair.
- To discuss the pharmacokinetic challenges and advanced delivery strategies for ICA in orthopedic therapy.
Main Methods
- Literature review of studies on Icariin's effects on bone cells and related pathways.
- Analysis of ICA's impact on bone remodeling, inflammation, and angiogenesis.
- Examination of ICA's pharmacokinetic properties and potential delivery systems.
Main Results
- ICA promotes osteogenic differentiation and bone matrix formation via Akt and Wnt/β-catenin pathways.
- ICA inhibits osteoclast activity, balancing bone remodeling for regeneration and reduced resorption.
- ICA demonstrates protective effects on multiple organs, optimizing the systemic environment for bone healing.
Conclusions
- Icariin (ICA) is a promising multi-target agent for bone regeneration due to its diverse actions.
- Pharmacokinetic limitations, including low oral bioavailability and short half-life, hinder ICA's clinical translation.
- Advanced drug delivery systems are crucial for enhancing ICA's bioavailability and therapeutic efficacy in orthopedic applications.
Related Concept Videos
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...

